🔴 MDxHealth is trading 13.58% down in pre-market; catalyst remains uncertain

MDxHealth is trading 13.58% down at $0.62 after no new company-specific announcement was identified for August 31, 2026.

• The latest notable development was BTIG’s August 21 price-target reduction to $2 from $4, citing the higher share count following MDxHealth’s $20 million stock offering.
• Broader markets are only modestly lower, so macro sentiment does not clearly explain the decline.